SCHEMBL24435591

SCHEMBL24435591

C[C@@H](OC(=O)C1Cc2ccccc2[C@@H](O)C1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.40
GRM7 Q14831 2/20 0.37
BLM P54132 1/20 0.37
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36
PSENEN Q9NZ42 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP3A4 P08684 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35
S1PR5 Q9H228 2/20 0.34
LMNA P02545 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
S1PR1 P21453 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9344185 0.76 TSHR (0.46) KMT2ACYP1A2TSHR
SCHEMBL27904989 0.76 HCAR2 (0.51) HCAR2BLMCYP3A4CYP1A2CYP2D6
SCHEMBL22791458 0.74 HCAR2 (0.46) HCAR2BLMS1PR5LMNASMN1; SMN2
SCHEMBL22791138 0.72 LMNA (0.58) HCAR2KMT2ACYP1A2CYP2D6TSHR
SCHEMBL15106469 0.70 HCAR2 (0.43) HCAR2BLMKMT2ACYP3A4HSD17B10
SCHEMBL15106471 0.70 HCAR2 (0.43) HCAR2BLMKMT2ACYP3A4HSD17B10
SCHEMBL15111271 0.70 HCAR2 (0.43) HCAR2BLMKMT2ACYP3A4HSD17B10
SCHEMBL22791211 0.70 HCAR2 (0.45) HCAR2BLMCYP3A4CYP1A2CYP2D6
SCHEMBL22791343 0.70 HCAR2 (0.45) HCAR2BLMKMT2AHSD17B10S1PR5
SCHEMBL22791467 0.70 HCAR2 (0.45) HCAR2BLMCYP3A4CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858951-B2 Boronic acid derivatives MERCK PATENT GMBH (DE) 2024-01-02 US disclosed
US-20220153761-A1 Boronic Acid Derivatives MERCK PATENT GMBH (DE) 2022-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153761-A1 Boronic Acid Derivatives PSMB7, PSMA7, BRD7 HCAR2 1982/4885GRM7 685/4885BLM 2249/4885
US-11858951-B2 Boronic acid derivatives PSMB7, PSMA7, BRD7 HCAR2 1982/4885GRM7 685/4885BLM 2249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.